| Early B cell changes predict autoimmunity following combination immune checkpoint blockade R Das, N Bar, M Ferreira, AM Newman, L Zhang, JK Bailur, A Bacchiocchi, ... The Journal of clinical investigation 128 (2), 715-720, 2018 | 352 | 2018 |
| Endogenous glucocorticoid signaling regulates CD8+ T cell differentiation and development of dysfunction in the tumor microenvironment N Acharya, A Madi, H Zhang, M Klapholz, G Escobar, S Dulberg, ... Immunity 53 (3), 658-671. e6, 2020 | 125 | 2020 |
| Dermatologic conditions in women receiving systemic cancer therapy MN Ferreira, JY Ramseier, JS Leventhal International journal of women's dermatology 5 (5), 285-307, 2019 | 42 | 2019 |
| Dermatologic toxicities associated with radiation therapy in women with breast cancer JY Ramseier, MN Ferreira, JS Leventhal International Journal of Women's Dermatology 6 (5), 349-356, 2020 | 41 | 2020 |
| Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy B Theivanthiran, N Yarla, T Haykal, YV Nguyen, L Cao, M Ferreira, ... Science translational medicine 14 (672), eabq7019, 2022 | 24 | 2022 |
| Guiding immunotherapy combinations: who gets what? MN Ferreira, JH Choe Advanced Drug Delivery Reviews 178, 113962, 2021 | 10 | 2021 |
| Evaluating the role of the COX2/PGE2 pathway in anti-melanoma immunity. M Ferreira, I Krykbaeva, W Damsky, HM Kluger, M Bosenberg Journal of Clinical Oncology 37 (15_suppl), e14114-e14114, 2019 | 5 | 2019 |
| Top Ten Tips Palliative Care Clinicians Should Know About Managing Immune-Mediated Endocrine Toxicities in Cancer MN Ferreira, M Rao, AH Kamal, A Shariff Journal of Palliative Medicine 25 (11), 1715-1720, 2022 | 2 | 2022 |
| Ibuprofen induces ferroptosis to potentiate antitumor immunity R Talty, M Ferreira, I Krykbaeva, M Bosenberg Cancer Research 82 (12_Supplement), 2166-2166, 2022 | 1 | 2022 |
| Advanced stage melanoma during pregnancy: Real-world management. JSW Borgers, DB Johnson, E Livingstone, EI Buchbinder, WA Robinson, ... Journal of Clinical Oncology 42 (16_suppl), 9540-9540, 2024 | | 2024 |
| 1254 Tumor-mediated education of bone marrow neutrophil progenitors facilitates the development of checkpoint inhibitor-associated toxicity B Thievanthiran, N Yarla, M Plebanek, M Ferreira, YV Nguyen, K Howell, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 1263 Characterizing steroid-refractory immunotherapy toxicities and effect of second-line immunosuppression on clinical outcomes M Ferreira, J Guo, T Jones, S Wolf, C Arrowood, D Niedzwiecki, BA Hanks Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Immune Checkpoint Inhibition J Isaacs, A Shariff, J Crawford, M Khouri, M Kheterpal, S Sammons, ... Side Effects of Cancer Therapy: Prevention and Treatment, 1-91, 2023 | | 2023 |
| Patterns of care delivery and outcomes in patients with melanoma brain metastases treated with ipilimumab/nivolumab. T Haykal, M Ferreira, M Lowe, BA Hanks, PE Fecci, JP Kirkpatrick, ... Journal of Clinical Oncology 41 (16_suppl), e21510-e21510, 2023 | | 2023 |
| Iatrogenic Cushing's syndrome presenting with adrenal insufficiency in 2 patients receiving dexamethasone for metastatic colorectal cancer through an intrahepatic arterial … MN Ferreira, AI Shariff Current Problems in Cancer: Case Reports 7, 100177, 2022 | | 2022 |
| Abstract PO064: Baseline steroids impair immunotherapy efficacy in a mouse model of melanoma M Ferreira, D Daniels, M Bosenberg Cancer Immunology Research 9 (2_Supplement), PO064-PO064, 2021 | | 2021 |
| Improving The Response To Checkpoint Inhibition And Characterizing New Treatments For Immune-Related Adverse Events In A Mouse Model Of Melanoma M Ferreira | | 2020 |
| Evaluating the impact of high-dose steroids on checkpoint inhibitor efficacy in a murine model of melanoma M Ferreira, W Damsky, M Bosenberg Journal of Investigative Dermatology 139 (5), S135-S135, 2019 | | 2019 |
